CMS Releases 2027 Hospital OPPS Final Rule

News | Published: Wednesday, November 4, 2026


ACC.org News Story - Updated November 12, 2026

The Centers for Medicare and Medicaid Services (CMS) has issued the 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule, finalizing a 2.3% increase to OPPS payment rates that reflects a market basket update of 3.2% reduced by a productivity adjustment of 0.9%.

Read about additional provisions from the final rule below.

  • Site Neutral Payment For Imaging Without Contrast: CMS finalized its proposal to pay for imaging services without contrast provided at previously “excepted” hospital off-campus provider-based departments at a lower rate like the Medicare Physician Fee Schedule.
  • Cardiac PET/CT APC Grouping/Payment: The agency finalized changes to reorganize nuclear imaging payment grouping so that PET/CT services are now assigned to clinical Ambulatory Payment Classifications (APCs) rather than new technology APCs. This change makes payment more stable for PET/CT services and does not greatly disrupt the APC families.
  • Inpatient-Only List/Covered Procedures List: Continuing the drive to remove obstacles that could limit access to care in different care settings, CMS advanced its plan to eliminate the inpatient-only (IPO) list by 2029, removing 637 services for auditory, digestive, endocrine, female genital, hemic and lymphatic systems, integumentary, male genital, maternity care and delivery, mediastinum and diaphragm, respiratory, and urinary services from the IPO. Separately, 619 services were added to the ASC Covered Procedures List (CPL), including nearly all of the services removed from the IPO.
  • Diagnostic Radiopharmaceuticals Payment Rate: For radiopharmaceuticals paid separately, CMS will continue setting reimbursement using the arithmetic mean unit cost as a proxy for the average price for a diagnostic radiopharmaceutical. The agency finalized $635 as the per-day cost threshold that triggers separate payment for diagnostic radiopharmaceuticals. This was lower than the proposed $665 threshold (based on more recent data) but an increase from the $630 threshold from 2026.
  • CCTA APC Assignment: Cardiac CT Angiography (CCTA) codes 75572-75574 were maintained in APC 5572 with a national base payment rate of $398.54, which the College supported, continuing a potentially temporary increase in reimbursement for these codes that started in 2025. CMS will continue to monitor data to determine future classification of these services.
  • Coronary Plaque Assessment APC assignment: CPT 75577 for coronary plaque assessment was maintained in APC 1511 with a national base payment rate of $950.50, which the College supported.
  • 340B Drug Payments: Payment for drugs acquired through the 340B Drug Pricing Program will be reduced from Average Sales Price (ASP) +6% to ASP –28% to align with a drug acquisition cost survey completed earlier this year. The initial proposal was ASP –33.4%.
  • Software as a Medical Service: CMS finalized a proposal to change terminology for algorithm-based software services paid under Medicare from "Software as a Service" (SaaS) to "Software as a Medical Service" (SaMS). The ACC was supportive of the change in terminology from SaaS to SaMS to refer to software-based technologies that diagnose disease and support clinical decision-making in outpatient and physician office settings, as defined by CMS, but recommended the agency clarify the specific criteria it plans to use in determining whether a service qualifies as SaMS.
  • Cardiac Rehabilitation: The Consolidated Appropriations Act of 2026 allows for the provision of cardiac rehabilitation, intensive cardiac rehabilitation and pulmonary rehabilitation services to hospital outpatients in their homes via audio and video real-time communications technology (excluding audio-only) through Dec. 31, 2027. CMS has issued sub-regulatory guidance to assist sites with performance and billing policies.
  • Hospital Outpatient Quality Reporting Program: CMS adopted ACC’s recommendation to delay STEMI electronic clinical quality measure validation penalties until 2028 reporting, using 2027 for education. However, CMS did not adopt protections for hospitals facing electronic health record or interoperability issues beyond their control.
  • ASC Quality Reporting Program: Regarding the All-Cause Hospital Transfer/Admission Measure, the ACC supported exploring phase-of-care stratification, with safeguards for patient complexity, reporting burden and measure reliability. CMS did not finalize a stratification framework.

For more information on the final rule, access the accompanying press release, fact sheet and addenda. Look for the latest information on ACC.org/Advocacy and in upcoming issues of the ACC Advocate newsletter.

Ok
This site uses cookies to improve your experience.

By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.